Breaking News

Financial Report: BASi

February 10, 2016

Service revenue down 22% in the quarter

Financial Report: BASi

4Q Revenues: $5.0 million (-23%)

4Q Loss: $721,000 (loss of $404,000 4Q14)

FY Revenues: $22.7 million (-8%)

FY Earnings: $1.1 million (loss of $1.1 million FY14)

Comments: Service revenue for the quarter decreased 22% to $3.8 million, negatively impacted by fewer bioequivalence studies, as well as fewer samples received and analyzed. Product revenue was $1.1 million, down 25% impacted by lower sales of analytical instruments relating to Culex.
  • Analytical Testing Outsourcing Trends Update

    Analytical Testing Outsourcing Trends Update

    January 26, 2017
    Spurred by many factors, global analytical testing services market is experiencing rapid growth in the range of 11% per year

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus